Inspiratory Muscle Training for Postmenopausal Women
(MRS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how inspiratory muscle strength training affects heart health and mood in postmenopausal women. Participants will use a device called PrO2 Fit (IMT Trainer) to perform breathing exercises at either high resistance or a lower, simulated level. Women who have not had a menstrual cycle for at least six years, have a BMI between 25.0 and 39.9, and can walk without assistance might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance heart health and mood in postmenopausal women.
Will I have to stop taking my current medications?
Yes, if you are currently using prescription medications that affect heart rate or blood vessel dilation, you will need to stop taking them to participate in this trial.
What prior data suggests that the PrO2 Fit (IMT Trainer) is safe for postmenopausal women?
Research shows that using the PrO2 Fit device for inspiratory muscle training (IMT) is generally safe. Studies have found that after eight weeks of high-intensity IMT, participants, especially those with lung conditions like bronchiectasis, developed stronger muscles and better endurance. These studies reported no major side effects or problems.
The research indicates no major safety concerns, suggesting that the treatment is well-tolerated. Participants often felt more confident and less dependent on medical help after using the device. While some faced challenges like attending sessions and staying motivated, these issues did not relate to the treatment's safety.
Overall, evidence suggests that IMT with PrO2 Fit is safe, enhancing muscle strength and confidence, with no significant safety issues reported in previous studies.12345Why are researchers excited about this trial?
Researchers are excited about Inspiratory Muscle Training (IMT) for postmenopausal women because it offers a unique approach to strengthening respiratory muscles. Unlike traditional treatments that focus on medication or general exercise, IMT specifically targets the inspiratory muscles, potentially improving breathing efficiency and overall respiratory health. The PrO2 Fit device used in this training offers a personalized and progressive challenge, which can adapt to the user’s capacity, making it a highly tailored intervention. By incorporating adjustable resistance and a structured progression, IMT may provide more targeted benefits than existing options.
What evidence suggests that the PrO2 Fit (IMT Trainer) is effective for improving cardiovascular health and mood disturbance in postmenopausal women?
Research shows that inspiratory muscle training (IMT) strengthens breathing muscles and enhances their endurance during activity. One study found that using the PrO2 Fit IMT trainer for eight weeks improved the strength and endurance of breathing muscles in people with bronchiectasis, a lung condition. Another study found that high-intensity IMT increased diaphragm thickness and lung capacity. For older women, IMT has boosted breathing strength. This trial will compare the effects of IMT using the PrO2 Fit device with a Sham-IMT group. These findings suggest that IMT may improve breathing ability and overall health, which could be especially beneficial for postmenopausal women.12456
Who Is on the Research Team?
Stephen J Carter, Ph.D
Principal Investigator
Indiana University, Bloomington
Are You a Good Fit for This Trial?
This trial is for postmenopausal women who are interested in how strengthening breathing muscles might improve heart health and mood. Details on specific inclusion or exclusion criteria were not provided, so it's best to contact the study team for more information.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle training (IMT) or sham IMT for 8 weeks, 4 times a week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PrO2 Fit (IMT Trainer)
Trial Overview
The trial is testing a device called PrO2 Fit, which is an Inspiratory Muscle Training (IMT) trainer. It aims to see if using this device can help with cardiovascular health and reduce mood disturbances in postmenopausal women.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
The test protocol requires participants to inhale maximally (maximum inspiratory pressure, MIP) against 2mm diameter leak and sustain inhalation (sustained maximal inspiratory pressure, SMIP) until task failure. Participants will complete 3 SMIP maneuvers with each training session and use the best of the three for that day's training template (corresponding to about 80% SMIP for the IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 5-seconds. The session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 4 times a week, and over 8-weeks.
Similar to the IMT group protocol, participants will be required to complete 3 SMIP maneuvers with each training session. Participants will use the best of the three for that day's training template (corresponding to about 30% SMIP for the Sham-IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 30-, 20-, 15-, 10-, and 5-seconds. The training session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 4 times a week, and over 8-weeks.
PrO2 Fit (IMT Trainer) is already approved in United States for the following indications:
- Rehabilitation for respiratory conditions
- Improvement of respiratory muscle strength and endurance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Published Research Related to This Trial
Citations
The Effect of a High-Intensity PrO2Fit Inspiratory Muscle ...
Eight weeks of IMT increased inspiratory muscle strength and endurance in those with bronchiectasis. IMT also had a positive effect on perceived competency and ...
"Inspiratory Muscle Training in Older Women"
Objective: To evaluate the effectiveness of two protocols of inspiratory muscle training (IMT) in older women to improve respiratory strength, ...
PrO2 - PrO2Health Research
The findings of this study suggest that high-intensity IMT results in increased contracted diaphragm thickness and increased lung volumes and exercise ...
Inspiratory Muscle Training in Postmenopausal Women
This study is being conducted by the Department of Kinesiology within the School of Public Health at Indiana University Bloomington.
The Effect of a High-Intensity PrO2Fit Inspiratory Muscle ...
The results emphasize the importance of mental health and disease severity as significant determinants of life quality in patients, particularly female patients ...
Adherence to and impact of home-based high-intensity IMT ...
The secondary outcomes in this study were respiratory pressures and volumes and FSB [1, 2]. Inspiratory measures obtained through the PrO2 ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.